Tiziana Life Sciences Net Income

Tiziana Life Sciences (TLSA) currently reports a net income of $-30M as of December 2025. That compares with $-24M in the prior-year period — down 23.8% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Tiziana Life Sciences's net income history and peer comparisons.

Tiziana Life Sciences's net income decreased from $-24M to $-30M — a 23.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tiziana Life Sciences's net income of $-30M is lower than the Healthcare sector average of $17B. That is roughly 100.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Tiziana Life Sciences reported $-30M in net income as of December 2025. That compares with $-24M in the prior-year period — down 23.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-30M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Tiziana Life Sciences, and consider following TLSA for alerts when major investors trade the stock.